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Abstract
Background—Little is known about the interaction between genetic and behavioral factors
during lifecycle risk periods for obesity and how associations vary across race/ethnicity.
Objective—To examine joint associations of adiposity-related single nucleotide polymorphisms
(SNPs) and moderate to vigorous physical activity (MVPA) with body mass index (BMI) in a
diverse adolescent cohort.
Methods—Using data from the National Longitudinal Study of Adolescent Health (n=8,113:
Wave II 1996; ages 12–21, Wave III; ages 18–27), we assessed interactions of 41 well-established
SNPs and MVPA with BMI-for-age Z scores in European Americans (EA; n=5,077), African
Americans (AA; n=1,736), and Hispanic Americans (HA; n=1,300).
Results—Of 97 assessed we found nominally significant SNP-MVPA interactions on BMI-for-
age Z score in EA at GNPDA2 and FTO and in HA at LZTR2/SEC16B. In EA the estimated effect
of the FTO risk allele on BMI-for-age Z score was lower (β=−0.13; 95% confidence interval (CI):
0.08, 0.18) in individuals with ≥ 5 versus < 5 (β=0.24; CI: 0.16, 0.32) bouts of MVPA per week (p
for interaction 0.02). Race/ethnicity-pooled meta-analysis showed nominally significant
interactions for SNPs at TFAP2B, POC5, and LYPLAL1.
Conclusions—High MVPA may attenuate underlying genetic risk for obesity during
adolescence, a high-risk period for adult obesity.
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GWAS have successfully identified more than 41 genetic loci that influence BMI in
European descent middle-aged adults [1]. Yet, little is known about the relevance of these
variants across race/ethnicity groups, their importance across the life course, or how they
interact with environmental and behavioral factors to influence obesity. Adolescence is a
high-risk period for the development of adult obesity [2, 3]. Physical activity (PA) is one of
the most promising behavioral candidates for preventing and reducing weight gain [4–6].
While there is evidence to support SNP by behavior interactions [7, 8], little is known about
whether physical activity mitigates genetic susceptibility to obesity during lifecycle periods
with the greatest potential for prevention and treatment.
The FTO locus is a well-studied common obesity variant that was among the first loci to
show evidence for gene by PA interaction in obesity studies, with a larger estimated effect
of the obesity risk allele at low levels of physical activity [9–12]. The majority of this
literature, however, has been limited to middle-aged adult populations of European descent,
although there has been work in African- and European-American adults [13], and a meta-
analysis of ethnically diverse youth and adults in which PA significantly attenuated the
association of FTO with obesity by 27% in adults but not youth [9].
We examined the interaction of 41 well-established obesity susceptibility SNPs with <5
versus ≥ 5 bouts MVPA per week in relation to BMI-for-age Z scores in a nationally
representative sample of European American (EA), African American (AA) and Hispanic
American (HA) adolescents. We hypothesized that physical activity would attenuate the
association between genetic variants associated with BMI. In addition, we hypothesized that
the joint role of moderate to vigorous physical activity and established obesity genetic
variants on body mass would vary by race/ethnicity.
METHODS
Subjects
National Longitudinal Study of Adolescent Health—The National Longitudinal
Study of Adolescent Health (Add Health) is a nationally representative, prospective cohort
of ethnically diverse adolescents representative of the U.S. school-based population in
grades 7 to 12 (11–22 years of age) in 1994–95 followed into adulthood. Add Health
selected a systematic random sample of 80 high schools and 52 middle schools in the United
States, stratified to ensure that the schools were representative of US schools with respect to
region, urbanicity, school type, percentage of white students, and school size at Wave I
(n=20,745)[14]. Respondents were followed through Wave II (n=14,738, 1996), Wave III
(2001–2002, n=15,197) and most recently Wave IV (2008–2009, n=15,701), when DNA
was first collected from all respondents, and consent given for banking and use in genetic
studies (n=12,234). Add Health included a core sample plus subsamples of selected
minorities, related adolescents (n=5,524), and other groups, including well-educated African
Americans, collected under protocols approved by the Institutional Review Board at the
University of North Carolina at Chapel Hill. The survey design and sampling frame have
been discussed elsewhere [15–17].
Race/Ethnicity
Since genetic biomarkers to determine ancestry were unavailable, we used a race/ethnicity
variable constructed from respondent and parental survey items on ancestral background and
family relationship status, creating a race/ethnicity variable with priority for agreement
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between participant and parental report. We used a three-category classification: non-
Hispanic European American (EA), non-Hispanic African American (AA), and Hispanic
American (HA). Within HA, we also classified subpopulation: Cuban, Puerto Rican,
Central/South Americans, Mexican, or Other Hispanic, as well as non-US born (first
generation immigrants), and US-born (2nd or 3rd generation immigrants).
Sibling Relatedness
Add Health oversampled related adolescents (n= 5,524) [18]. Familial relatedness was
classified according to participant and parental self-report. Twin zygosity was confirmed by
11 molecular genetic markers [19].
Genetic characterization—The 41 SNPs genotyped in the current study were selected
based on 43 SNPs identified in published GWAS for their association with BMI at the time
of our study (37 variants); obesity (4 variants), and central adiposity (2 variants) in European
descent individuals [20–28].
Genotyping was performed using TaqMan assays and the ABI Prism 7900® Sequence
Detection System (Applied Biosystems, Foster City, CA, USA). Sequences for primers and
TaqMan probes are available upon request. The genotype call rate ranged from 97.8% to
98.2% and the discordance rate between blind duplicate pairs was (1/277, 0.3%). We
excluded SNPs with too few observations (<10) in any combination of genotype by MVPA
interaction (EA, n=1, rs11847697; HA, n=4, rs6548238, rs13107325, rs10508503,
rs4788102), and (AA, n=8, rs6548238, rs13107325, rs12444979, rs228701, rs98723,
rs2605100, rs545854, rs1805081). SNPs that failed tests for Hardy-Weinberg Equilibrium
(HWE) within race/ethnicity groups (n=1, rs2922763) were excluded, resulting in 41 SNPs
listed in Table S1.
Criteria for generalizability—Across all race/ethnicity groups generalizability was
defined as similar direction of effect as reported in the literature (which is primarily
European-descent populations) and nominal statistical significance (p<0.05) [29]. Thus,
generalizability in the EA subpopulation is straightforward. A recent large GWA study in
AA (Monda et al., submitted) suggests that some SNPs identified in EA populations fail to
generalize in AA samples either due to limited power or linkage disequilibrium differences
resulting in failure to capture the signal of the functional variant [30]. We excluded 14 SNPs
with no evidence for generalization in AA (i.e., SNP effect estimates were directionally
inconsistent and evidence for association p>0.20 in a large GWAS in African descent
samples) (Monda et al., submitted). Given the lack of large GWA studies in Hispanics, all
SNPs were considered for HA. In sum, we considered 41 SNPs in EA, 37 in HA, and 19 in
AA for this analysis.
Body Mass Index (BMI)—Weight and height were measured during in-home surveys
using standardized procedures. BMI (kg/m2) was calculated using measured height and
weight assessed at Wave II or III when participants were aged 12–21 years, with priority for
younger age at measurement (Wave II: n=14,646) unless the respondent was not seen at
Wave II (Wave III: n=785) and was still between the ages of 12–21 years. Self-reported
height and weight were substituted for those refusing measurement and/or weighing more
than the scale capacity (Wave II n=119; Wave III n=34). Self-reported height and weight
were substituted for those refusing measurement and/or weighing more than the scale
capacity (Wave II n=119; Wave III n=34). The Add Health self-reported weight and height
correlate strongly with measured weight (r=0.95) and height (r=0.94) [22]. Given the age
range from 12 to 21 years there is substantial heterogeneity in growth. Thus, we used BMI-
for-age Z scores in central analyses and weight- and height-for-age Z scores in sub-analyses.
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Moderate-to-vigorous physical activity—Weekly frequency (bouts) of leisure-time
MVPA (skating & cycling, exercise, and active sports) were queried at Waves II and III
using a standard, interviewer administered activity recall based on validated questionnaires
[31]. The questionnaire included activities relevant to adolescents at Wave II and was
modified at Wave III to include age-appropriate activities; Wave III bouts were scaled for
comparability with Wave II [32]. To explicitly test estimated effects for obesity SNPs
relative to the recommendation for MVPA for adolescents at the time of study (i.e., ≥5 bouts
of MVPA/wk American Cancer Society 2001), MVPA was dichotomized to high (≥5)
versus low (<5) bouts per week using the Wave at which height and weight were measured
(i.e. height and weight measured at Wave III then Wave III MVPA data was used).
Analytic sample—At Wave IV 59% (n=12,234) of the original Wave I (n=20,745)
respondents provided samples with consent for banking and use in genetic studies from
which DNA was extracted and genotyped (n=12,066). To be eligible for the current study,
each individual had to have at least 80% of their 41 SNPs genotyped (n=11,448) and be
between the ages of 12 and 21 years at either Waves II or III (n=9,129). Among the 9,129
eligible adolescents, we excluded the following participants: the monozygotic twin with
fewer genotyped loci within each twin pair (n=139), individuals of Native American (n=57)
or Asian (n=437) or unclassified (n=69) race/ethnicity due to insufficient sample size,
pregnant (n=110), disabled (n=47), and those with missing data for: geographic region
(n=67), BMI (n=2), current smoking (n=1), race/ethnicity (n=43), MVPA (n=2), or screen
time (n=42). The final analytic sample included 8,113 individuals (Figure 1).
Statistical analysis: Association analyses were conducted using Stata, version 12.1 (Stata
Corp, College Station, Texas) and were stratified by race/ethnicity. We used means and
proportions to describe the study population. In race/ethnicity-stratified, multivariable
models, we controlled for age, sex, current smoking status (≥1 cigarette every day for 30
days), screen time (hours of screen time from television, video, and computer games per
week), geographic region, and an indicator for self-reported heights and weights (n=86),
with additional controls in AA models: oversampling of highly educated AAs (n=355), and
in HA models: Hispanic ancestry: Cuban (n=193), Puerto Rican (n=224), Central/South
American (n=120), Mexican (n=660), and other Hispanic (n=103), and foreign born (n=
268). Sample design effects and familial relatedness were accounted for in all multivariable
linear models using separate random effects for school and family.
We assessed interactions between MVPA and each of the SNPs (41 in EA, 37 in HA; 19 in
AA) using likelihood ratio tests comparing the log likelihoods between the main effects
model and the models with a MVPA-by-SNP interaction variable. We also calculated betas
for interaction, SNP and MVPA terms from nominally significant (p < 0.05) interaction
models as well as risk allele frequencies and estimated main effects of each SNP on BMI-
for-age, weight-for-age, and height-for-age Z score. To allow for inference of nominally
significant interaction model results, we estimated the main effects of each SNP on BMI-
for-age Z score stratified by high versus low MVPA. To test the hypothesis that MVPA may
have a more potent attenuation effect in the more overweight subjects, we conducted a
sensitivity analysis to determine whether interactions were more robust in the overweight
and obese subjects using the (pediatric IOTF cut-off points that correspond to BMI>=25 kg/
m2 in adults [33].
In addition, as we expected some effect estimates to be similar across race/ethnicity, we
performed a race/ethnicity pooled inverse variance weighted meta-analysis using beta
estimates from the models described above, implemented in the program METAL [34]. We
included the AA in the meta-analysis to: 1) increase power by including all populations and
2) minimize bias that would occur if only the populations that had an effect were selected.
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Multiple testing correction: To correct for multiple testing, we set the statistical
significance threshold at α equal to 0.05/number of SNPs tested: 41 in EA; p=0.0012, 19 in
AA; p= 0.0026, and 37 in HA; p= 0.0014. However, as this analysis is focused on the
estimation of effects for established genetic variants, we interpreted all findings achieving
nominal statistical significance.
RESULTS
Add Health includes a racially/ethnically diverse sample of American adolescents, as is
reflected in the descriptive characteristics (Table 1). BMI, height, weight, current smoking,
and MVPA varied across race/ethnicity, with about 60% of adolescents reporting high
MVPA.
The SNPs considered (41 in EA; 37 in HA; 19 in AA) in the present study are shown in
Table S1. Three SNP by MVPA interaction BMI effect estimates were nominally significant
(P<0.05) in association with BMI-for-age Z score, with variation by race/ethnicity: two in
EA (GNPDA2 (rs10938397) and FTO (rs9939609)), one in HA LZTR2/SEC16B (rs543874)
and none in AA (Table 2). None reached significance with Bonferroni correction for the
number of SNPs interrogated.
Allele frequencies (Tables S2) and main effects of SNPs for BMI-for-age Z-scores (Table
S3) varied across race/ethnicity. Main effects for weight-for-age and height-for-age Z-scores
are shown in Tables S4 and S5. To illustrate the effect of the risk allele in each strata of
MVPA, we plotted the main effect of each SNP on BMI-for-age in race/ethnic groups
separately in Figure 2. The estimated effect of the risk allele on BMI-for-age Z score was
attenuated in individuals with high versus low levels of MVPA (Figure 2). Genotype
frequencies are shown in Table S6. For SNP by MVPA associations in the overweight/obese
subsample [n= 2,548 (EA: 1,457; AA: 636; HA: 455)] interaction effect sizes were
moderately attenuated compared to the central analysis and none were nominally significant
(p>0.05) Table (S7).
In the race/ethnicity pooled meta-analysis (Table 3) we detected directionally consistent
effect estimates for the FTO and GNPDA2 SNPs observed in the EA sample. Two additional
SNPs, POC5 (rs2112347) and TFAP2B (rs987237), showed attenuation in BMI-for-age Z
score with high MVPA for each copy of the risk allele. An additional SNP, LYPLAL1
(rs2605100), showed higher BMI-for-age Z score with high MVPA for each copy of the risk
allele. Findings for FTO and GNPDA2 showed larger estimated effect size than in the EA
stratum (Tables 2 and 3).
DISCUSSION
In this large and nationally representative sample of US adolescents, we found that high
levels of MVPA appear to attenuate the influence of three genetic variants on BMI-for-age Z
score during a major risk period for the development of adult obesity [2, 3]. In addition,
there was variation in these effect estimates across race/ethnicity. The estimated effect sizes
differed between high and low MVPA by approximately 0.2 BMI-for-age Z score units
observed across the 2 loci (FTO (rs9939609), GNPDA2 (rs10938397)) in the EA
subpopulations.
The different allele frequencies by race/ethnicity reflect the different patterns of population
histories in EA, AA, and HA. In general, main SNP effects on BMI-for-age Z scores were
very similar in direction and statistical significance as those estimated on BMI across race/
ethnicity in a separate analysis [29]. We observed nominally significant (p<0.05) main SNP
effects on BMI-for-age Z score for two SNPs (EA, n=1; rs12444979) and (AA, n=1;
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rs7138803) that did not have nominally significant associations with BMI. Conversely we
observed two SNPs (AA, n=1; rs2241423) and (HA, n=1; rs571312) with main effects on
BMI-for-age Z score that did have nominally significant associations with BMI. In the race/
ethnicity pooled meta-analysis, the increase in BMI-for-age Z score per copy of the FTO,
GNPDA2, POC5, and TFAPB2 risk alleles was 0.4 BMI-for-age Z score units greater in
individuals with low versus high MVPA. We also observed a nominally significant
interaction between MVPA and a SNP in/near LYPLAL1 (associated with WC [24]),
although the effect of the BMI increasing allele was heightened in the high MVPA group.
While GWAS in populations of European descent have identified several common BMI
candidates for adults, little is known about adolescence, a lifecycle period with great
potential for obesity prevention and treatment. Even less is known about how obesity
susceptibility loci interact with modifiable behaviors, such as MVPA [4–6], which are
known to prevent weight gain. The few gene-by-environment interactions investigated in
adolescents have mainly interrogated the single FTO locus [9, 35–38]. Although associated
variants typically implicate genomic regions rather than individual genes, we note that some
of the loci presented in this study underlie positional candidate genes with interesting and
established connections to obesity [39–42].
The risk allele of FTO (rs9939609) has been reported to interact with PA [9, 35, 37, 38],
possibly increasing weight gain susceptibility through energy balance regulation via the
central nervous system through expression in the arcuate nucleus of the hypothalamus [43].
Our findings in the EA subpopulation and in the race/ethnicity pooled meta-analysis support
the previously reported FTO by PA association.
We also observed nominally significant interactions (attenuation of BMI in combination
with MVPA) in EA for SNPs in or near the GNPDA2 gene that encodes Glucosamine-6-
phosphate deaminase, involved in the biosynthesis of glucosamine and expressed in the
hypothalamus [44]. In the overweight/obese subsample analysis, the nominally significant
SNP by MVPA interactions in the EA and HA lost statistical significance most likely
because of lack of power or possibly due to timing of MVPA relative to weight gain, which
could have obscured interaction effects. There is clearly a need for additional study of SNP
by MVPA interactions in longitudinal samples with longer periods of follow-up to fully
understand the nature of the temporal relationships that lead to weight gain.
Our findings may lend further support to the role of neuronal pathways in relation to BMI
through energy balance, potentially via appetitive and satiety mechanisms [45]. We
observed a nominally significant SNP by MVPA interaction for TFAPB2 (which may play a
role in energy balance and inflammation [46]) in association with BMI-for-age Z score in
the race/ethnicity pooled meta-analysis. The fact that physical activity can lead to temporary
appetite suppression [47], suggests some biologically plausible support for the observed
attenuation of obesity risk allele associations by MVPA near the TFAPB2, GNPDA2 and
FTO genes.
We also observed a nominally significant SNP by MVPA interaction for the POC5 and
LYPLAL1 loci in association with BMI-for-age Z score in the race/ethnicity pooled meta-
analysis. LYPLAL1 supports potentially important mitigating pathways related to fatty acid
metabolism and glucose uptake by adiponectin [48] and POC5 is a gene necessary for
building the distal half of centrioles [49]. In HA, we observed evidence for an interaction
between a SNP in or near SEC16B/LZTR2 in relation to BMI-for-age Z score.
Obesity genetics research has largely focused on European descent populations limiting the
ability for comparative research in minority populations at greatest risk for obesity [50].
Furthermore, the small number of racially/ethnically diverse cohorts with high quality
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phenotype, behavior and genetic data prohibits the investigation of gene-by-environment
interactions in many minority populations. It is notable, however, that the few gene-by-
environment interaction studies that have been conducted in minority populations have
observed differential findings by race/ethnicity [35, 48]. One challenge is that different
linkage disequilibrium patterns across ancestral populations reduce the ability to detect
associations. For example, ancestry specific linkage disequilibrium patterns may underlie
the attenuated estimates of well-established FTO obesity related variants originally
identified in Europeans in African-descent populations, despite adequate statistical power
[51].
We recognize multiple testing is a substantial issue in the analyses of gene-environment
interactions. We attempted to limit the impact of this problem by focusing extensive
analyses only on those SNPs with well-established main effects in European descent
populations as well as SNPs that have been shown to generalize in African ancestry
populations. Although this strategy led to fewer statistical tests, it may have introduced some
bias. Furthermore, while we interpret the findings of nominally significant interactions as
likely to represent significant genotype-by MVPA interactions, another and perhaps more
simple explanation may be that there is insufficient power to detect association in the high/
or low activity strata. Clearly further independent research is needed to confirm and refine
this work.
While our study capitalizes upon a racially/ethnically diverse nationally representative
cohort measured during a unique period of the lifecycle, there are limitations to consider.
First, the lack of established obesity loci in all race/ethnicity groups is a limitation,
particularly in HA, where there have not been large GWAS. As larger genome-wide
association and sequencing studies of African-and Hispanic-descent individuals are
published, more information will clarify the population differences in the genetic
architecture of obesity. Second, we rely on self-reported physical activity behaviors, where
objective and precise measures of energy expenditure might have increased power to detect
associations of interest. However, there are no large, ethnically diverse population studies
with such data. Third, we lack ancestry informative markers to account for population
admixture. However, as these loci are well established, our inferences are unlikely to be
unduly influenced by cryptic population stratification. Fourth, there may be more complex
interactions such as gene-by-gene and/or gene-by-unmeasured environmental influences that
might influence BMI, such as dietary patterns. Lastly, in our cross-sectional analysis we are
unable to assess temporal relationships with MVPA behavior patterns and BMI change over
time. Further longitudinal research is needed. Despite these limitations, our study uses well-
established obesity loci to investigate the joint role of MVPA and established obesity
variants on BMI during adolescence.
Conclusions
Our findings suggest that higher levels of MVPA may attenuate the influence of obesity
susceptibility variants on BMI during adolescence. Whether the observed race/ethnicity
differences indicate true differences across populations or limited power to detect effects
remains to be seen. As more studies become available, replication of these findings in large,
ethnically diverse samples, and broadly across the lifecycle, will be important.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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ABBREVIATIONS
MVPA Moderate to Vigorous Physical Activity
PA Physical Activity
SNP Single Nucleotide Polymorphism
GWA Genome-Wide Association
EA non-Hispanic European American
AA non-Hispanic African American
HA Hispanic American
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What is already known about this subject
- GWAS have successfully identified numerous genetic loci that influence
BMI in European descent middle-aged adults.
- Adolescence is a high-risk period for the development of adult obesity and
severe obesity.
- Physical activity (PA) is one of the most promising behavioral candidates for
preventing and reducing weight gain, particularly among youth
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What this study adds
- An examination of the joint association between 41 of the well-established
obesity susceptibility SNPs with <5 versus ≥ 5 bouts MVPA per week in
relation to BMI-for-age Z score in a nationally representative sample of
European American, African American and Hispanic American adolescents.
- Three nominally significant interactions (p<0.05) varied by race/ethnicity.
- Overall, the estimated effect of the risk allele on BMI-for-age Z score was
greater in individuals with < 5 than those with ≥ 5 bouts MVPA per week.
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Analysis Sample, derived from The National Longitudinal Study of Adolescent Health
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Estimated effects1 for BMI-for-age Z score per one copy of risk allele in the 3 SNPs with
nominally significant interactions2 by high versus low MVPA3 and across European
American and Hispanic American subpopulations
Abbreviation: MVPA moderate to vigorous physical activity, EA, European American, AA,
African American, HA, Hispanic American
1 MVPA stratified model: Multi-level model of adolescent BMI-for-age Z score regressed
on SNP, controlling for age, sex, current smoking (at least one cigarette every day for 30
days), screen time (hours of screen time from television, video, and computer games per
week), region, an indicator for self-reported heights and weights where necessary.
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Additional race/ethnicity information was controlled for in the non-EA subpopulations:
oversampling of highly educated African Americans (AA stratum only), Hispanic
subpopulation ancestry, as well as an indicator for foreign born (HA stratum only). Separate
random effects allowed for individual, family and school with no sample weighting. Models
run separately for each SNP, by high and low MVPA and race/ethnicity. P values corrected
for multiple testing are α equal to 0.05/number of SNPs tested (0.0012 in EA and 0.0014 in
HA).
2 Likelihood ratio tests were used to assess statistical interaction between the main effects
(no interaction term) model and the interaction model, separately for each SNP by race/
ethnicity.
3 High MVPA: 5 or more bouts per week of MVPA, low MVPA: less than 5 bouts per week
of MVPA
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Table 1
Study population characteristics, The National Longitudinal Study of Adolescent Health
European American African American Hispanic American Total
N 5,077 1,736 1,300 8,113
Age, mean (SD), y 16 (1.8) 16 (1.9) 17 (1.8) 16.4 (1.8)
Male sex, n (%) 2,404 (47.4) 777 (44.8) 641 (49.3) 3,822 (47.1)
BMI1, mean (SD) 23.0 (5.0) 24.2 (5.8) 23.9 (5.3) 23.4 (5.3)
BMI-for-age Z scores, mean (SD) 0.30 (1.1) 0.53 (1.1) 0.46 (1.1) 0.38 (1.1)
Weight-for-age Z scores, mean (SD) 0.53 (1.1) 0.69 (1.1) 0.42 (1.2) 0.55 (1.1)
Height-for-age Z scores, mean (SD) 0.43 (1.0) 0.35 (1.1) −0.12 (1.1) 0.33 (1.1)
MVPA2, mean (SD) [range] 6.2 (3.9) [0, 16.5] 5.6 (3.6) [0, 16.5] 5.7 (3.8) [0, 16.5] 6 (3.8) [0, 16.5]
High MVPA3, n (%) 3,324 (63.5) 1,053 (58.8) 782 (58.2) 5,008 (61.7)
Screen time, mean (SD), h/wk 19.1 (16.9) 27.6 (22.2) 21.3 (17.8) 21.3 (18.6)
Current smoking, n (%) 1,420 (27.1) 166 (9.3) 216 (16.1) 1,750 (21.6)
Geographic region, n (%)
   West 780 (15.4) 246 (14.2) 525 (40.4) 1,551 (19.1)
   Midwest 1,862 (36.7) 332 (19.1) 96 (7.4) 2,290 (28.2)
   South 1,668 (32.9) 1,059 (61.0) 495 (38.1) 3,222 (39.7)
   Northeast 767 (15.1) 99 (5.7) 184 (14.2) 1,050 (12.9)
Abbreviation: MVPA moderate to vigorous physical activity, BMI Body Mass Index
Unless otherwise indicated, data are presented as number (column percentage).
1
Calculated as weight in kilograms divided by height in meters squared.
2
Bouts of MVPA per week
3
High: 5 or more bouts of MVPA per week
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Table 2
Model results for the three nominally significant interactions (p<0.05)1 between adiposity related loci by
MVPA2 in association with BMI-for-age Z scores, by race/ethnicity and main effects on BMI-for-age Z scores
β (95% CI)
European American
FTO (rs9939609 per copy of A allele) 0.23 (0.16, 0.30)
MVPA (high versus low) 0.12 (0.02, 0.21)
rs9939609 × MVPA −0.10 (−0.19, 0.21)
p for interaction1 0.024
GNPDA2 (rs10938397 per copy of G allele) 0.11 (0.03, 0.18)
MVPA (high versus low) 0.12 (0.02, 0.22)
rs10938397 × MVPA −0.09 (−0.18, −0.00)
p for interaction1 0.045
Main effects
FTO (rs9939609 per copy of A allele) 0.16 (0.12,0.21)
MVPA (high versus low) 0.04 (−0.03, −0.10)
GNPDA2 (rs10938397 per copy of G allele) 0.05 (0.00, 0.09)
MVPA (high versus low) 0.04 (−0.02, 0.11)
Hispanic American
LZTR2/SEC16B (rs543874 per copy of G allele) 0.29 (0.13, 0.46)
MVPA (high versus low) 0.02 (−0.13, 0.17)
rs5438749 × MVPA −0.33 (−0.55, −0.11)
p for interaction1 0.003
Main effects
LZTR2/SEC16B (rs543874 per copy of G allele) 0.10 (−0.01, 0.21)
MVPA (high versus low) −0.10 (−0.23, 0.03)
Abbreviations: SNP, single nucleotide polymorphism, BMI, body mass index, MVPA, moderate to vigorous physical activity, CI, confidence
interval
1
Beta estimates are presented for the SNP, MVPA, SNP by MVPA interaction terms, and main effects in the interacted multivariable linear model
of adolescent BMI-for-age Z scores regressed on SNP, MVPA, and SNP-by-MVPA interaction, controlling for age, sex, current smoking, screen
time, region, indicator for self-reported heights and weights, oversampling of highly educated African Americans (AA stratum only), Hispanic
subpopulation ancestry, as well as an indicator for foreign born (HA stratum only). Random effects allowed for individual, family and school with
no sample weighting. Models were run separately for each SNP and race/ethnicity. Likelihood ratio tests were used to assess statistical interaction
between the main effects (no interaction term) model and the interaction model, separately for each SNP by race/ethnicity. P values corrected for
multiple testing are α equal to 0.05/number of SNPs tested (0.0012 in EA and 0.0014 in HA).
2
High MVPA: 5 or more bouts per week of MVPA, low MVPA: less than 5 bouts per week of MVPA
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Table 3
Model results for the five nominally significant interactions (p<0.05)1 between adiposity related loci by
MVPA2 in association with BMI-for-age Z scores in the race/ethnicity pooled meta-analysis sample3
β (95% CI)
FTO (rs9939609 per copy of A allele) −0.43 (−0.76, −0.42)
p for interaction3 0.009
GNPDA2 (rs10938397 per copy of G allele) −0.42 (−0.08, −0.45)
p for interaction3 0.01
POC5 (rs2112347 per copy of T allele) −0.41 (−0.77, −0.35)
p for interaction3 0.03
LYPLAL1 (rs2605100 per copy of the G allele) 0.42 (0.80, 0.36)
p for interaction3 0.03
TFAP2B (rs987237 per copy of G allele) −0.44 (−0.01, −0.53)
p for interaction3 0.045
Abbreviations: SNP, single nucleotide polymorphism, BMI, body mass index, MVPA, moderate to vigorous physical activity, CI, confidence
interval
1
Beta estimates are presented for the SNP, MVPA and SNP by MVPA interaction terms in the interacted multivariable linear model of adolescent
BMI-for-age Z scores regressed on SNP, MVPA, and SNP-by-MVPA interaction, controlling for age, sex, current smoking, screen time, region,
indicator for self-reported heights and weights, oversampling of highly educated African Americans (AA stratum only), Hispanic subpopulation
ancestry, as well as an indicator for foreign born (HA stratum only). Random effects allowed for individual, family and school with no sample
weighting. Models were run separately for each SNP and race/ethnicity. Likelihood ratio tests were used to assess statistical interaction between the
main effects (no interaction term) model and the interaction model, separately for each SNP by race/ethnicity. P- value corrected for multiple
testing is 0.0012.
2
High MVPA: 5 or more bouts per week of MVPA, low MVPA: less than 5 bouts per week of MVPA
3
Beta estimates are presented for the meta-analysis of race/ethnicity pooled sample estimates shown for SNP by MVPA interaction models in
METAL [34]. The Z test was used to assess statistical interaction using comparison of SNP by MVPA interaction estimates.
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